HUM vs LYRA · P/E 39, rev $117.76B vs rev $1.5M
Humana Inc (HUM) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the HUM and LYRA stock pages for the full models.
Not investment advice.